Day One Biopharmaceuticals (DAWN)
(Real Time Quote from BATS)
$16.24 USD
-0.18 (-1.10%)
Updated May 16, 2024 12:32 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Brokerage Reports
Day One Biopharmaceuticals, Inc. [DAWN]
Reports for Purchase
Showing records 41 - 60 ( 67 total )
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Topline FIREFLY-1 Snapshot Shines Bright; NDA on Track for 1H:23; PT to $38
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
FIREFLY-1&2 Light a Clear Path for Tovorafenib in pLGG and Beyond; Initiating Coverage With a Buy Rating and $35 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; FIREFLY-1 Topline Results Ahead in 1Q:23
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Q2 Financials; FIREFLY-1 Topline Results 1Q:23, NDA Filing Potential in 1H:23
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
FIREFLY-1 Interim Data Reported; Updates from the Investor Call
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
FIREFLY-1 Interim Data Glows; Positive Update on 1L Study Design; PT to $35
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Q1 Financials; FIREFLY-1 Ph 2 Data Ahead in June
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Q1 Financials; FIREFLY-1 Ph 2 Data Ahead in June
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
4Q Financials; FIREFLY-1 Hits Target Enrollment; Initial Data Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R